# Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique

> **NCT03499886** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Isfahan University of Medical Sciences** · enrollment: 198 (estimated)

## Conditions studied

- Procedural Sedation

## Interventions

- **DRUG:** Ketamine Hydrochloride 50Mg/1mL Solution for Injection
- **DRUG:** Ketamine Hcl 50Mg/Ml Inj

## Key facts

- **NCT ID:** NCT03499886
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-17
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-05-14
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499886, "Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03499886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*